Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$17.13 - $26.91 $227,246 - $356,988
13,266 New
13,266 $273,000
Q1 2021

May 17, 2021

SELL
$127.04 - $179.1 $1.95 Million - $2.75 Million
-15,380 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$99.96 - $135.93 $143,942 - $195,739
1,440 Added 10.33%
15,380 $1.98 Million
Q3 2020

Nov 13, 2020

SELL
$80.32 - $111.8 $2.63 Million - $3.66 Million
-32,730 Reduced 70.13%
13,940 $1.56 Million
Q2 2020

Aug 14, 2020

BUY
$60.49 - $97.5 $2.82 Million - $4.55 Million
46,670 New
46,670 $3.79 Million
Q1 2020

May 15, 2020

SELL
$59.04 - $88.81 $3.37 Million - $5.06 Million
-57,000 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$59.49 - $82.78 $3.39 Million - $4.72 Million
57,000 New
57,000 $4.45 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.23B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.